Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

NETWORK 2OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Cardiotoxicity 4Lymphoma 3Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1Osteosarcoma 1Lymphoma, Large-Cell, Anaplastic 1Localized Extraskeletal Ewing Sarcoma 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia 1Ganglioneuroblastoma 1Burkitt Lymphoma 1

Interventions

Ifosfamide 19Doxorubicin 19Filgrastim 17Radiotherapy 13Vincristine 11Cyclophosphamide 11Etoposide 9Cisplatin 9Granulocyte Colony-Stimulating Factor 8Gene Expression Profiling 8Trabectedin 7Polymerase Chain Reaction 7Dactinomycin 6sargramostim 5etoposide phosphate 5Paclitaxel 5Mesna 5Chemotherapy, Adjuvant 4Brachytherapy 4pegfilgrastim 3Topotecan 3Microarray Analysis 3Irinotecan 3Immunohistochemistry 3Imatinib Mesylate 3Gemcitabine 3Dexrazoxane 3Base Sequence 3olaparib 2brostallicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Sarcoma × Razoxane × Clear all
NCT00003937 2014-08-05

Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma

Children's Oncology Group

Phase 3 Completed
253 enrolled
Sarcoma

Sarcoma, Cardiotoxicity

NCT00742924 2014-07-04

Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Children's Oncology Group

Phase 1 Completed
24 enrolled 9 charts
Sarcoma

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡